FORWARD FEATURES CALENDAR

Find us on

Latest News

Idinvest Partners has appointed Alban Wyniecki as an investment director. Wyniecki will provide strategic direction and oversight of Idinvest’s Growth Capital Fund II, which recently held its first close at EUR250 million.   The fund’s first investment this year was in Vestiaire Collective, an online e-commerce marketplace for pre-loved clothes.   “We are very much looking forward to Alban joining the Growth team here at Idinvest,” says Benoist Grossmann, managing partner at Idinvest. “We are currently seeing a good amount of opportunity for European companies looking to scale-up, particularly in the tech sector and where Alban brings a huge amount
Cambridge Innovation Capital (CIC) has appointed Michael Anstey as an investment director specialising in healthcare investments. Anstey says: “There is an abundance of impressive innovation in bioscience occurring in the Cambridge Cluster. We are on the cusp of something fantastic here. It's exciting to be part of an opportunity in a growth phase and I think it's the perfect time to join this world class team and build something great.”   Anstey was previously a principal in the Healthcare Practice of The Boston Consulting Group (BCG) in Toronto, Canada. He brings experience in advising multinational healthcare businesses across North America,
BGF (Business Growth Fund) has appointed Fiona Gibson to support its growing portfolio in the South West of England. Gibson joins BGF from Lloyds Banking Group where she was head of equity investments, responsible for the bank’s portfolio of more than 250 legacy equity assets. Whilst at Lloyds, Gibson delivered a number of significant exits including the sale of Keepmoat and CALA Homes.   With 15 years’ private equity experience, predominately managing minority equity investments across a range of sectors, Gibson worked at 3i and HBoS Integrated Finance before moving into the equity investments team at Lloyds Banking Group following
IBID Group, an investment firm focused on buying and investing in internet-based companies with high growth potential, has expanded its gaming portfolio with the majority acquisition of Riverplay, an end-to-end platform for the online gaming industry. Following the acquisition, Riverplay will be re-branded as Pragmatic Solutions.   Pragmatic Solutions is an API-based integrated customer relationship management and content management system that provides gaming, entertainment and financial services operators with a one-stop solution for digital growth. The platform offers the content management, administration, payments, marketing and third party solutions needed to build rapid and sustainable digital success. In Pragmatic Solutions, IBID
Forterra, a manufacturer of water infrastructure pipe and products in the US and Eastern Canada, has acquired the business of Royal Enterprises America (Royal), a manufacturer of concrete drainage pipe, precast concrete products, stormwater treatment technologies and erosion control products. Terms of the transaction were not disclosed.      Based in Stacy, Minnesota, Royal primarily serves the greater Minneapolis market. The acquisition of Royal is expected to provide Forterra access to new opportunities for growth in the strong and expanding Minneapolis housing and infrastructure market.   "We expect Royal will further accelerate Forterra's growth in the drainage and stormwater management
Matthew Pohlman has rejoined law firm Goodwin as a partner in the hospitality and leisure practice in the London office. Pohlman brings extensive experience in the development, operation, management, acquisition, disposition and financing of hotels, resorts and other mixed-use hospitality assets around the world.   “We are delighted to welcome Matt back to Goodwin,” says Teresa Goebel, partner in the real estate industry group. “Merging his extensive international hospitality experience with our capabilities in Europe and the US will further expand our offering to hospitality and leisure clients, especially those with active interests in Europe, the Middle East, Africa and
Exonate, an early stage biotechnology company, has been awarded a GBP4.9 million seeding drug discovery award by the Wellcome Trust to continue development of an eye-drop treatment for wet age-related macular degeneration. Exonate is bolstered further by a recent funding round of GBP1.5 million from new and existing shareholders at the end of 2016.   The Wellcome Trust investment will be used to accelerate the development of Exonate’s first in class molecules – a topical eye drug as a much-needed alternative to current treatment by injections for wet age-related macular degeneration (AMD).   Exonate have developed small molecules that inhibit
By Ras Sipko, KOGER – For the past four years, alternative fund managers with US investors have been coming to terms with the far-reaching effects of the Foreign Account Tax Compliance Act or FATCA. Some 60-plus countries have signed up to cooperate with the IRS in order to enforce FATCA and this year the compliance burden is set to grow yet again. On 31st May 2017, fund managers will have to submit their first filing under the OECD Common Reporting Standards initiative, which can best be thought of as global FATCA or 'GATCA'. Creating an internal programme to comply with FATCA/GATCA
James Williams, Hedgeweek
There are a number of encouraging developments in Ireland that would, on the surface, appear to place it on a strong footing to further enhance its reputation as Europe's leading onshore alternative funds jurisdiction.  If one looks at fund growth, through October 2016 (the most recent figures at the time of writing) the aggregate AUM of Irish QIAIFs increased by 7 per cent with net sales reaching EUR10 billion. At the end of 2015, total assets in Irish ICAV fund structures stood at EUR6.2 billion. By the end of October 2016, that figure had risen to EUR26.5 billion.  "The ICAV
Cyril Delamere
ML Capital, one of Ireland's leading management company groups, has grown to exceed EUR3 billion of AUM over the last 12 months. The growth trajectory over recent years has enabled ML Capital to evolve from being a leading UCITS platform operator to being more of a fund solutions provider to managers and investors alike.  "They come to us, tell us what they need and we give them the best fund structure and solution; whether this is going on to one of our platforms and launching a sub-fund and using us as the third party ManCo to perform all the operational

Special Reports

Featured

Events

12 November, 2026 – 8:00 am

Directory Listings